Contract 75D30123F00001
Glaxosmithkline, Llc · Department Of Health And Human Services · October 28, 2022
Glaxosmithkline, Llc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on October 28, 2022 for $90.03 million of work in medicinal and botanical manufacturing. Performance is in Durham, NC. This is a task or delivery order issued under parent IDIQ 75D30123D16461. The contract has been modified 139 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 26, 2026.
Contract details
- PIID
- 75D30123F00001
- Parent IDIQ
- 75D30123D16461
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Not Competed
- NAICS
- 325411 · Medicinal And Botanical Manufacturing
- Product / service
- Support- Management: Other
- Place of performance
- Durham, NC
- First action
- October 28, 2022
- Latest action
- February 26, 2026
Description
ADMIN MOD - BORROW / RETURN OF STOCKPILE VACCINE DOSES
Modification timeline
-
February 26, 2026Mod P00011$0
-
January 29, 2026Mod P00010$0
-
January 9, 2026Mod P000032023 D1-A05 WASTEWATER SURVEILLANCE, LTCAH AND NH FOR AR$-592.7K
-
September 26, 2025Mod P00009$0
-
September 25, 2025Mod P00005DHQP SUPPORT SERVICES$135.0K
-
September 25, 2025Mod P00005PROFESSIONAL SEVICES IN RWANDA$0
-
September 24, 2025Mod P000032023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ$163.9K
-
September 24, 2025Mod P000022023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ$193.2K
-
September 23, 2025Mod P00004DHQP SUPPORT SERVICES$948.5K
-
September 18, 2025Mod P000032023 CLINICAL IMMUNIZATION SAFETY ASSESSMENT (CISA) BASE IDIQ$218.3K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| United Oxygen Company, Inc. | Department Of Health And Human Services | March 23, 2026 | $46.9K |
| Ohio State University, The | Department Of Health And Human Services | February 10, 2026 | $0 |
| Rotem Inc | Department Of Health And Human Services | January 28, 2026 | $19.8K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | January 22, 2026 | $0 |
| Roche Diagnostics Corporation | Department Of Health And Human Services | January 12, 2026 | $12.3K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | January 12, 2026 | $18.4K |
Top contractors in NAICS 325411
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 372,977 | $24.02B |
| 2 | Amerisourcebergen Drug Corp | 1,414,856 | $18.32B |
| 3 | Glaxosmithkline, Llc | 44 | $5.42B |
| 4 | Merck Sharp & Dohme Llc | 3 | $1.50B |
| 5 | Novartis Vaccines And Diagnostics, Inc. | 132 | $1.07B |
| 6 | Sanofi Vaccines Us Inc. | 57 | $650.53M |
| 7 | Cardinal Health, Inc. | 42,916 | $603.29M |
| 8 | Dms Pharmaceutical Group Inc | 113,930 | $547.06M |
| 9 | Cardinal Health 100, Inc | 7,655 | $486.24M |
| 10 | Glaxosmithkline Holdings (Americas) Inc. | 72 | $280.01M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30123F00001?
Contract 75D30123F00001 is a federal contract awarded to Glaxosmithkline, Llc by Department Of Health And Human Services on October 28, 2022 for $90.03 million of work classified under MEDICINAL AND BOTANICAL MANUFACTURING. It has been modified 139 times since the base award.
Who won contract 75D30123F00001?
Glaxosmithkline, Llc won contract 75D30123F00001 from Department Of Health And Human Services.
How much is contract 75D30123F00001 worth?
Contract 75D30123F00001 has obligated $90.03 million to date.